Skip to main content

Table 2 Antimalarial treatments for children with uncomplicated malaria presenting to all health facilities – change of practice between 2004 and 2006 surveys in four districts in Zambia

From: Paediatric malaria case-management with artemether-lumefantrine in Zambia: a repeat cross-sectional study

2004 5–9 kg (N = 527) ≥ 10 kg (N = 394)
  No (%) 95% CI* No (%) 95% CI*
   Artemether-lumefantrine 6 (1.1) 0, 2.7 42 (10.7) 5.4, 16.0
   Sulphadoxine-pyrimethamine 422 (80.1) 73.9, 86.2 266 (67.5) 58.8, 76.2
   Quinine 14 (2.7) 0.8, 4.5 19 (4.8) 2.0, 7.6
   Chloroquine 1 (0.2) 0, 0.6 0 NA
   No antimalarial prescribed 84 (15.9) 10.3, 21.6 67 (17.0) 11.7, 22.3
2006 5–9 kg (N = 552) ≥ 10 kg (N = 547)
  No (%) 95% CI* No (%) 95% CI*
   Artemether-lumefantrine 149 (27.0) 19.2, 34.8 231 (42.2) 33.8, 50.7
   Sulphadoxine-pyrimethamine 214 (38.8) 30.9, 46.7 151 (27.6) 19.9, 35.3
   Quinine 26 (4.7) 1.5, 7.9 38 (7.0) 2.5, 11.4
   No antimalarial prescribed 163 (29.5) 23.3, 35.8 127 (23.2) 17.9, 28.5
  1. * Confidence intervals adjusted for cluster sampling